Syros Pharmaceuticals Inc...
(SYRS)
undefined
undefined%
At close: undefined
0.26
0.04%
Pre-market Jan 07, 2025, 06:07 AM EST
Cashflow (Annual)
Get detailed ratio statement breakdowns, uncovering price to free cash flow ratio, price per earnings, and much more.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 |
| Net Income | -164.57M | -94.65M | -86.56M | -84.04M | -75.44M | -62.28M | -54.01M | -47.74M | -29.82M | -13.43M | -8.66M |
| Depreciation & Amortization | 2.25M | 2.97M | 3.02M | 3.04M | 2.72M | 1.60M | 1.53M | 1.27M | 602.00K | 258.00K | 170.00K |
| Stock-Based Compensation | 10.43M | 11.41M | 10.35M | 10.94M | 9.84M | 6.61M | 4.42M | 4.23M | 3.23M | 937.00K | 821.00K |
| Other Working Capital | -1.77M | -8.28M | -12.64M | -6.35M | 19.54M | 13.50M | -870.00K | -284.00K | 914.00K | -67.00K | 86.00K |
| Other Non-Cash Items | 37.13M | -37.27M | 706.00K | 2.32M | 7.24M | -642.00K | -102.00K | 10.00K | 17.00K | 334.00K | 394.00K |
| Deferred Income Tax | n/a | n/a | -16.46M | 326.00K | -1.13M | n/a | n/a | n/a | n/a | n/a | n/a |
| Change in Working Capital | 5.05M | -5.52M | -10.60M | 10.05M | -3.48M | 14.39M | 3.44M | 1.69M | 2.94M | 267.00K | 86.00K |
| Operating Cash Flow | -109.71M | -123.06M | -99.54M | -57.36M | -60.25M | -40.31M | -44.73M | -40.54M | -23.03M | -11.97M | -7.19M |
| Capital Expenditures | -272.00K | -1.24M | -1.25M | -3.34M | -12.64M | -1.38M | -821.00K | -2.32M | -1.18M | -201.00K | -878.00K |
| Acquisitions | n/a | n/a | n/a | n/a | 110.00K | 9.00K | n/a | n/a | n/a | n/a | n/a |
| Purchase of Investments | -50.97M | n/a | -51.41M | n/a | -108.21M | -96.77M | -41.77M | -25.02M | n/a | n/a | n/a |
| Sales Maturities Of Investments | 87.02M | 68.43M | n/a | 50.00M | 109.00M | 87.50M | 27.00M | n/a | n/a | n/a | n/a |
| Other Investing Acitivies | 1.56M | 68.43M | -51.41M | 50.00M | 904.00K | 9.00K | -14.77M | -25.02M | n/a | n/a | n/a |
| Investing Cash Flow | 37.34M | 67.19M | -52.65M | 46.66M | -11.73M | -10.64M | -15.59M | -27.34M | -1.18M | -201.00K | -878.00K |
| Debt Repayment | -65.00K | -291.00K | -265.00K | 39.38M | -205.00K | -50.00K | -168.00K | -135.00K | -50.00K | n/a | n/a |
| Common Stock Repurchased | n/a | -81.00K | n/a | n/a | n/a | n/a | n/a | n/a | -620.00K | n/a | n/a |
| Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Other Financial Acitivies | 257.00K | 11.66M | 439.00K | 1.30M | 5.01M | 626.00K | 1.80M | 40.21M | 392.00K | 137.51M | 10.04M |
| Financial Cash Flow | 43.46M | 131.04M | 70.51M | 142.95M | 65.99M | 69.08M | 33.94M | 90.56M | -278.00K | 68.76M | 10.04M |
| Net Cash Flow | -28.91M | 75.17M | -81.68M | 132.25M | -6.00M | 18.13M | -26.38M | 22.68M | -24.48M | 56.59M | 1.97M |
| Free Cash Flow | -109.98M | -124.31M | -100.78M | -60.70M | -72.89M | -41.70M | -45.55M | -42.86M | -24.21M | -12.17M | -8.07M |